|30.03||-0.4100||-1.35%||Vol 634.05K||1Y Perf -33.20%|
|Jan 20th, 2022 15:56 DELAYED|
|- -%||- -|
|Target Price||43.50||Analyst Rating||Moderate Buy 2.50|
|Potential %||41.37||Finscreener Ranking||★★★★+ 54.85|
|Insiders Trans % 3/6/12 mo.||-/-100/-100||Value Ranking||★★★★+ 61.07|
|Insiders Value % 3/6/12 mo.||-/-100/-100||Growth Ranking||★★★★ 57.39|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-100/-100||Income Ranking||— -|
|Price Range Ratio 52W %||6.84||Earnings Rating||Strong Sell|
|Market Cap||682.40M||Earnings Date||23rd Feb 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||23rd Feb 2022|
|Estimated EPS Next Report||-0.76|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||325.09K|
|Avg. Monthly Volume||247.96K|
|Avg. Quarterly Volume||250.46K|
Inogen Inc (NASDAQ: INGN) stock closed at 30.44 per share at the end of the most recent trading day (a 0.07% change compared to the prior day closing price) with a volume of 467.30K shares and market capitalization of 682.40M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 938 people. Inogen Inc CEO is Scott Wilkinson.
The one-year performance of Inogen Inc stock is -33.2%, while year-to-date (YTD) performance is -10.47%. INGN stock has a five-year performance of -52.11%. Its 52-week range is between 26.19 and 82.35, which gives INGN stock a 52-week price range ratio of 6.84%
Inogen Inc currently has a PE ratio of 64.20, a price-to-book (PB) ratio of 1.79, a price-to-sale (PS) ratio of 2.49, a price to cashflow ratio of 20.90, a PEG ratio of 2.32, a ROA of 2.36%, a ROC of 2.90% and a ROE of 3.09%. The company’s profit margin is 5.88%, its EBITDA margin is 8.80%, and its revenue ttm is $281.60 Million , which makes it $12.39 revenue per share.
Of the last four earnings reports from Inogen Inc, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.76 for the next earnings report. Inogen Inc’s next earnings report date is 23rd Feb 2022.
The consensus rating of Wall Street analysts for Inogen Inc is Moderate Buy (2.5), with a target price of $43.5, which is +41.37% compared to the current price. The earnings rating for Inogen Inc stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Inogen Inc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Inogen Inc has a Sell technical analysis rating based on Technical Indicators (ADX : 13.41, ATR14 : 1.66, CCI20 : -96.63, Chaikin Money Flow : 0.22, MACD : -0.81, Money Flow Index : 41.78, ROC : -10.47, RSI : 38.40, STOCH (14,3) : 48.79, STOCH RSI : 0.64, UO : 51.77, Williams %R : -51.21), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Inogen Inc in the last 12-months were: Alison Bauerlein (Option Excercise at a value of $1 468 040), Alison Bauerlein (Sold 76 247 shares of value $4 527 737 ), Bart Sanford (Sold 273 shares of value $0 ), Brenton Taylor (Option Excercise at a value of $1 774 398), Brenton Taylor (Sold 70 961 shares of value $3 861 623 ), Byron Myers (Option Excercise at a value of $236 070), Byron Myers (Sold 14 204 shares of value $738 097 ), Loren L. Mcfarland (Option Excercise at a value of $155 929), R. Scott Greer (Option Excercise at a value of $896 998), Raymond O. Huggenberger (Option Excercise at a value of $817 779), Raymond O. Huggenberger (Sold 24 681 shares of value $1 522 417 )
Tue, 11 Jan 2022 15:24 GMT Inogen (INGN) Receives a Hold from Leerink Partners- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
This could take some time, please wait.